http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010034787-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b77fbaebe146adda9fb9cdf42e7bde6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_681222b7248c7c884530b2de730a0c7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_540478758a2bded5dc7d746713fc081f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ccd9173f2aabd93562c916f9a2dbff4 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
filingDate | 2009-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17b2000c7f407630c211678664d917b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93b617a238eb5b817f2dce254a8cdd83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_871e88418024e771501d77696d9e46b2 |
publicationDate | 2010-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2010034787-A1 |
titleOfInvention | Antimicrobial peptides |
abstract | The present invention relates to a peptide comprising or consisting of the following amino acid sequence: A0-A1 -A2-A3-A4-A5-A6-A7-A8-A9-A10-A11 -A12 (formula II), wherein AO is a hydrophobic amino acid residue or is absent; A1, A4, A7, A8, A12 each are a hydrophobic amino acid residue; and A2, A6, A9, A10 each are a basic amino acid residue; A5 is an alanine or a basic amino acid residue; A3, A1 1 each are a basic amino acid residue, or a hydrophobic amino acid residue; or a peptidomimetic thereof; wherein the basic amino acid residues are selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residues are selected from the group consisting of leucine, alanine, isoleucine, valine, methionine and phenylalanine; and wherein said peptide or peptidomimetic has antimicrobial and/or antiviral activity. Furthermore, the invention relates to a nucleic acid molecule encoding the peptide of the invention, a vector comprising the nucleic acid molecule as well as a host cell comprising the nucleic acid molecule or the vector. The present invention also relates to a method for producing the peptide of the invention, a composition as well as to the peptide or peptidomimetic of the invention for use in treating infectious diseases. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2020294324-B2 |
priorityDate | 2008-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 303.